The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update
Open accessAbstract
Summary: Psoriasis vulgaris is a common and often chronic inflammatory skin disease.The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence‐based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque‐type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Psoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial
Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,379
Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet Light
Parrish, J. A., Fitzpatrick, T. B., Tanenbaum, L., & Pathak, M. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197412052912301 · Cited by 1,376
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Self-citationEtanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Boonstra, A., Barrat, F. J., Crain, C., Heath, V. L., Savelkoul, H. F. J., & O’Garra, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4974 · Cited by 1,123
Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069
Reich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045
Self-citationGesundheitsberichterstattung des Bundes
Ti (2010) · Krankenhaus-Hygiene + Infektionsverhütung · doi:10.1016/j.khinf.2010.03.002 · Cited by 1,024
Definition of treatment goals for moderate to severe psoriasis: a European consensus
Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., et al. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-010-1080-1 · Cited by 898
Self-citationEfficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J. T., & Tsuji, W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20335 · Cited by 882
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
O'Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J., & O'Neill, E. A. (1992) · Nature · doi:10.1038/357692a0 · Cited by 841
Kabat-Zinn, J., Wheeler, E., Light, T., Skillings, A., Scharf, M. J., Cropley, T. G., Hosmer, D., & Bernhard, J. D. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199809000-00020 · Cited by 826
Saurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 798
Stern, R. S., Nijsten, T., Feldman, S. R., Margolis, D. J., & Rolstad, T. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09102.x · Cited by 732
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C., Krueger, G. G., de Vlam, K., Birbara, C., Beutler, A., Guzzo, C., Zhou, B., Dooley, L. T., & Kavanaugh, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032268 · Cited by 715
Papp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study
Gisondi, P., Tessari, G., Conti, A., Piaserico, S., Schianchi, S., Peserico, A., Giannetti, A., & Girolomoni, G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07986.x · Cited by 675
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
Sommer, D. M., Jenisch, S., Suchan, M., Christophers, E., & Weichenthal, M. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0703-z · Cited by 667
Gottlieb, A., Menter, A., Mendelsohn, A., Shen, Y.-K., Li, S., Guzzo, C., Fretzin, S., Kunynetz, R., & Kavanaugh, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60140-9 · Cited by 585
Gottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Menter, A., Feldman, S. R., Weinstein, G. D., Papp, K., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Arnold, C., & Gottlieb, A. B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516
Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Epidemiology and comorbidity of psoriasis in children
Augustin, M., Glaeske, G., Radtke, M. A., Christophers, E., Reich, K., & Schäfer, I. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09593.x · Cited by 494
Self-citationElevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
ETTEHADI, P., GREAVES, M. W., WALLACH, D., ADERKA, D., & CAMP, R. D. R. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06244.x · Cited by 481
Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque Psoriasis
Heydendael, V. M. R., Spuls, P. I., Opmeer, B. C., de Borgie, C. A. J. M., Reitsma, J. B., Goldschmidt, W. F. M., Bossuyt, P. M. M., Bos, J. D., & de Rie, M. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021359 · Cited by 475
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
Smith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., Chandler, D. A., Finlay, A. Y., Griffiths, C. E. M., Jackson, K., McHugh, N. J., et al. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09505.x · Cited by 464
Elias, K. M., Laurence, A., Davidson, T. S., Stephens, G., Kanno, Y., Shevach, E. M., & O'Shea, J. J. (2008) · Blood · doi:10.1182/blood-2007-06-096438 · Cited by 448
Cyclosporine for Plaque-Type Psoriasis: Results of a Multidose, Double-Blind Trial
Ellis, C. N., Fradin, M. S., Messana, J. M., Brown, M. D., Siegel, M. T., Hartley, A. H., Rocher, L. L., Wheeler, S., Hamilton, T. A., Parish, T. G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240501 · Cited by 429
Capon, F., Di Meglio, P., Szaub, J., Prescott, N. J., Dunster, C., Baumber, L., Timms, K., Gutin, A., Abkevic, V., Burden, A. D., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0397-0 · Cited by 408
Van Ede, A. E., Laan, R. F. J. M., Rood, M. J., Huizinga, T. W. J., Van De Laar, M. A. F. J., Denderen, C. J. V., Westgeest, T. A. A., Romme, T. C., De Rooij, D.-J. R. A. M., Jacobs, M. J. M., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1515::aid-art273>3.0.co;2-7 · Cited by 401
Methotrexate in psoriasis: Consensus conference
Roenigk, H. H., Auerbach, R., Maibach, H., Weinstein, G., & Lebwohl, M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70508-0 · Cited by 393
Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients
Mallbris, L., Akre, O., Granath, F., Yin, L., Lindelöf, B., Ekbom, A., & Ståhle-Bäckdahl, M. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000020447.59150.f9 · Cited by 390
Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study
Paul, C. F., HO, V. C., McGeown, C., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12040.x · Cited by 388
Psoriasis: a possible risk factor for development of coronary artery calcification
Ludwig, R. J., Herzog, C., Rostock, A., Ochsendorf, F. R., Zollner, T. M., Thaci, D., Kaufmann, R., Vogl, T. J., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07562.x · Cited by 374
Self-citationMethotrexate and histologic hepatic abnormalities: A meta-analysis
Whiting-O'Keefe, Q. E., Fye, K. H., & Sack, K. D. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80060-9 · Cited by 358
GUBNER, R. S., August, S., & Ginsberg, V. (1951) · PubMed · Cited by 343
Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany
Augustin, M., Reich, K., Glaeske, G., Schaefer, I., & Radtke, M. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0770 · Cited by 337
Self-citationScheinfeld, N. S. (2004) · Journal of Dermatological Treatment · doi:10.1080/09546630410017275 · Cited by 316
Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis
FINLAY, A. Y., KHAN, G. K., LUSCOMBE, D. K., & SALEK, M. S. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb04192.x · Cited by 314
Gubner, R., August, S., & Ginsberg, V. (1951) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195102000-00009 · Cited by 308
Gisondi, P., Del Giglio, M., Di Francesco, V., Zamboni, M., & Girolomoni, G. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26427 · Cited by 307
Antipsoriatic effect of fumaric acid derivatives
Altmeyer, P. J., Mattlies, U., Pawlak, F., Hoffmann, K., Frosch, P. J., Ruppert, P., Wassilew, S. W., Horn, T., Kreysel, H. W., Lutz, G., et al. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70121-0 · Cited by 300
A classification of psoriasis vulgaris according to phenotype
Griffiths, C. E. M., Christophers, E., Barker, J. N. W. N., Chalmers, R. J. G., Chimenti, S., Krueger, G. G., Leonardi, C., Menter, A., Ortonne, J.-P., & Fry, L. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07675.x · Cited by 295
NEVITT, G. J., & HUTCHINSON, P. E. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1035.x · Cited by 281
Objective Assessment of Compliance With Psoriasis Treatment
Zaghloul, S. S., & Goodfield, M. J. D. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.4.408 · Cited by 281
Augustin, M., Krüger, K., Radtke, M. A., Schwippl, I., & Reich, K. (2008) · Dermatology · doi:10.1159/000119415 · Cited by 271
Self-citationMethotrexate for psoriasis. A new therapeutic schedule
Weinstein, G. D. (1971) · Archives of Dermatology · doi:10.1001/archderm.103.1.33 · Cited by 268
Grassberger, Baumruker, Enz, Hiestand, Hultsch, Kalthoff, Schuler, Schulz, Werner, Winiski, et al. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02974.x · Cited by 267
Marcil, I., & Stern, R. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06179-7 · Cited by 258
Matz, H., Orion, E., & Wolf, R. (2003) · Dermatologic Therapy · doi:10.1046/j.1529-8019.2003.01622.x · Cited by 256
Patients with psoriasis and their compliance with medication☆, ☆☆, ★, ★★
RICHARDS, H., FORTUNE, D., OSULLIVAN, T., MAIN, C., & GRIFFITHS, C. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70301-4 · Cited by 255
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy
Fortune, D. G., Richards, H. L., Kirby, B., Bowcock, S., Main, C. J., & Griffiths, C. E. M. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04622.x · Cited by 255
Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells
Treumer, F., Zhu, K., Gläser, R., & Mrowietz, U. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12605.x · Cited by 248
Self-citationCoven, T. R. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.12.1514 · Cited by 232
de Jong, R., Bezemer, A. C., Zomerdijk, T. P. L., van de Pouw‐Kraan, T., Ottenhoff, T. H. M., & Nibbering, P. H. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260916 · Cited by 226
Takeuchi, A., Reddy, G. S., Kobayashi, T., Okano, T., Park, J., & Sharma, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.209 · Cited by 209
Dimethylfumarate for psoriasis: more than a dietary curiosity
MROWIETZ, U., & ASADULLAH, K. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.11.003 · Cited by 206
Self-citationMenter, A., Augustin, M., Signorovitch, J., Yu, A. P., Wu, E. Q., Gupta, S. R., Bao, Y., & Mulani, P. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.07.022 · Cited by 197
Self-citationTreatment of psoriasis with fumaric acid esters: results of a prospective multicentre study
Mrowietz, Christophers, Altmeyer, & STUDY, T. P. I. T. G. M. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02124.x · Cited by 197
Biological therapies in the systemic management of psoriasis: International Consensus Conference
Sterry, W., Barker, J., Boehncke, W.-H., Bos, J. D., Chimenti, S., Christophers, E., De La Brassinne, M., Ferrandiz, C., Griffiths, C., Katsambas, A., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06070.x · Cited by 194
Self-citationA randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis
Gordon, P. M., Diffey, B. L., Matthews, J. N. S., & Farr, P. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70008-3 · Cited by 191
Caproni, M., Antiga, E., Melani, L., Volpi, W., Del Bianco, E., & Fabbri, P. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9233-0 · Cited by 181
Efficacy of the 308-nm excimer laser for treatment of psoriasis: Results of a multicenter study
Feldman, S. R., Mellen, B. G., Housman, T. S., Fitzpatrick, R. E., Geronemus, R. G., Friedman, P. M., Vasily, D. B., & Morison, W. L. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120454 · Cited by 180
Takeuchi, A., Reddy, G. S., Kobayashi, T., Okano, T., Park, J., & Sharma, S. (1998) · PubMed · Cited by 179
Topical Tacrolimus Is Not Effective in Chronic Plaque Psoriasis: A Pilot Study
Zonneveld, I. M., Rubins, A., Jablonska, S., Dobozy, A., Ruzicka, T., Kind, P., Dubertret, L., & Bos, J. D. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.9.1101 · Cited by 174
Guenther, L., Cambazard, F., Van De Kerkhof, P. C. M., Snellman, E., Kragballe, K., Chu, A. C., Tegner, E., Garcia-Diez, A., & Springborg, J. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04967.x · Cited by 172
Revicki, D., Willian, M. K., Saurat, J.-H., Papp, K. A., Ortonne, J.-P., Sexton, C., & Camez, A. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08236.x · Cited by 168
Acitretin plus UVB therapy for psoriasis
Lowe, N. J., Prystowsky, J. H., Bourget, T., Edelstein, J., Nychay, S., & Armstrong, R. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70089-k · Cited by 167
de Korte, J., Mombers, F. M. C., Sprangers, M., & Bos, J. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.9.1221 · Cited by 167
Reitamo, S., Spuls, P. I., Sassolas, B., Lahfa, M., Claudy, A., Griffiths, C. E. M., & FOR THE SIROLIMUS EUROPEAN PSORIASIS STUDY GROUP (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04376.x · Cited by 161
Ockenfels, Schultewolter, Ockenfels, Funk, & Goos (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02400.x · Cited by 161
Vandermeeren, M., Janssens, S., Borgers, Μ., & Geysen, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6570 · Cited by 160
Flytström, I., Stenberg, B., Svensson, Å., & Bergbrant, I.-M. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08284.x · Cited by 160
Malatjalian, D. A., Ross, J. M., Williams, C. N., Colwell, S., & Eastwood, B. J. (1996) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/1996/213596 · Cited by 155
Mussi, A., Bonifati, C., Carducci, M., D’Agosto, G., Pimpinelli, F., D'Urso, D., D'Auria, L. M., de Fázio, M. R., & Ameglio, F. (1997) · PubMed · Cited by 152
Yones, S. S., Palmer, R. A., Garibaldinos, T., & Hawk, J. L. M. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.7.836 · Cited by 151
Zachariae, C. O. C., Mørk, N. J., Reunala, T. L., Lorentzen, H. F., Falk, E., Karvonen, S., Johannesson, A., Clareus, B., Skov, L., Mørk, G., et al. (2008) · Acta Dermato Venereologica · doi:10.2340/00015555-0511 · Cited by 148
Schmitt, J. M., & Ford, D. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03537.x · Cited by 147
A psychocutaneous profile of psoriasis patients who are stress reactors
Gupta, M. A., Gupta, A. K., Kirkby, S., Schork, N. J., Gorr, S. K., Ellis, C. N., & Voorhees, J. J. (1989) · General Hospital Psychiatry · doi:10.1016/0163-8343(89)90036-4 · Cited by 146
Saurat, J. ‐., Geiger, J.-M., Amblard, P., Béani, J.-C., Boulanger, A., Claudy, A., Frenk, E., Guilhou, J. J., Grosshans, E., Mérot, Y., et al. (2009) · Dermatologica · doi:10.1159/000248567 · Cited by 144
Gisondi, P., Giglio, M. D., Cotena, C., & Girolomoni, G. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08564.x · Cited by 143
The role of salicylic acid in the treatment of psoriasis
Lebwohl, M. (1999) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1999.00500.x · Cited by 139
Weinstein, G. D., Koo, J. Y. M., Krueger, G. G., Lebwohl, M., Lowe, N. J., Menter, A., Lew‐Kaya, D. A., Sefton, J., Gibson, J. R., & Walker, P. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.103 · Cited by 137
Tacrolimus ointment improves psoriasis in a microplaque assay
Remitz, Reitamo, Erkko, Granlund, & Lauerma (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02927.x · Cited by 134
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
Nast, A., Kopp, I., Augustin, M., Banditt, K., Boehncke, W., Follmann, M., Friedrich, M., Huber, M., Kahl, C. R., Klaus, J., et al. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0744-y · Cited by 129
Self-citationOrtiz, Z., Shea, B., Suarez-Almazor, M. E., Moher, D., Wells, G. A., & Tugwell, P. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000951 · Cited by 126
Acitretin improves psoriasis in a dose-dependent fashion
Goldfarb, M. T., Ellis, C. N., Gupta, A. K., Tincoff, T., Hamilton, T. A., & Voorhees, J. J. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70086-9 · Cited by 125
Mrowietz, U., Elder, J. T., & Barker, J. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0707-8 · Cited by 125
Self-citationThe mechanisms of action of cyclosporin A in the treatment of psoriasis
Wong, R. L., Winslow, C. M., & Cooper, K. D. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90061-o · Cited by 124
Gudjonsson, J. E., Kárason, A., Antonsdóttir, A. A., Rúnarsdóttir, E. H., Hauksson, V. B., Upmanyu, R., Gulcher, J. R., Stefánsson, K., & Valdimarsson, H. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05115.x · Cited by 118
Inhibition of Dendritic Cell Differentiation by Fumaric Acid Esters
Zhu, K., & Mrowietz, U. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01159.x · Cited by 116
Self-citationLebwohl, M. G., Yoles, A., Lombardi, K., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70323-8 · Cited by 115
Markham, T., Rogers, S., & Collins, P. M. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.3.325 · Cited by 114
Schmid‐Ott, G., Jaeger, B., Adamek, C., Koch, H., Lamprecht, F., Kapp, A., & Werfel, T. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.111850 · Cited by 113
Self-citationSystemic therapy with fumaric acid derivates: New possibilities in the treatment of psoriasis
Nieboer, C., de Hoop, D., Loenen, A. C. V., et al. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70071-2 · Cited by 111
IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases
Sabat, R., Wallace, E., Endesfelder, S., & Wolk, K. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.601 · Cited by 110
Methotrexate Hepatotoxicity in Psoriasis
Robinson, J. K. (1980) · Archives of Dermatology · doi:10.1001/archderm.1980.01640280049016 · Cited by 109
Combined methotrexate-PUVA therapy in the treatment of psoriasis
Morison, W. L., Momtaz-T, K., Parrish, J. A., & Fitzpatrick, T. B. (1982) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(82)70005-2 · Cited by 108
COMPARISON OF PHOTOCHEMOTHERAPY AND DITHRANOL IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS
Rogers, S., MARKS, J. M., Shuster, S., Briffa, D. V., WARIN, A. P., & Greaves, M. W. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90820-1 · Cited by 107
Hagemann, I. S., & Proksch, E. (1996) · Acta Dermato Venereologica · doi:10.2340/0001555576353356 · Cited by 103
A Pilot Study of Hypnosis in the Treatment of Patients with Psoriasis
Tausk, F., & Whitmore, S. E. (1999) · Psychotherapy and Psychosomatics · doi:10.1159/000012336 · Cited by 102
Tazarotene plus UVB phototherapy in the treatment of psoriasis
Koo, J. Y. M., Lowe, N. J., Lew‐Kaya, D. A., Vasilopoulos, A. I., Lue, J. C., Sefton, J., & Gibson, J. R. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107940 · Cited by 102
Frequency of Malignant Neoplasms in 248 Long-Term Methotrexate-Treated Psoriatics
Nyfors, A., & Jensen, H. (2009) · Dermatologica · doi:10.1159/000249793 · Cited by 97
Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal
Boffa, M. J., Chalmers, R. J. G., Haboubi, N. Y., Shomaf, M. S., & MITCHELL, D. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb02754.x · Cited by 97
Evidence‐based (S3) guidelines for the treatment of psoriasis vulgaris
Nast, A., Kopp, I., Augustin, M., Banditt, K., Boehncke, W., Follmann, M., Friedrich, M., Huber, M., Kahl, C. R., Klaus, J., et al. (2007) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2007.06172.x · Cited by 95
Self-citationAsawanonda, P., & Nateetongrungsak, Y. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.01.004 · Cited by 93
Combined methotrexate-ultraviolet B therapy in the treatment of psoriasis
Paul, B. S., Momtaz-T, K., Stern, R. S., Arndt, K. A., & Parrish, J. A. (1982) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(82)70157-4 · Cited by 91
Murray, H. E., Anhalt, A. W., Lessard, R., Schachter, R. K., Ross, J. M., Stewart, W. D., & Geiger, J. M. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70091-f · Cited by 88
Lauharanta, J., & Geiger, J. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01406.x · Cited by 87
Kircik, L., Bagel, J., Korman, N. J., Menter, A., Elmets, C. A., Koo, J. Y. M., Yang, Y., Chiou, C., Dann, F. J., & Stevens, S. R. (2008) · PubMed · Cited by 86
Saijo, S., Asano, M., Horai, R., Yamamoto, H., & Iwakura, Y. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10172 · Cited by 85
Mittal, R., Malhotra, S., Pandhi, P., Kaur, I., & Dogra, S. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.5 · Cited by 85
Medium-dose 308-nm excimer laser for the treatment of psoriasis
Trehan, M., & Taylor, C. R. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.125075 · Cited by 82
Newman, M. (1989) · Archives of Dermatology · doi:10.1001/archderm.125.9.1218 · Cited by 79
A new treatment of ichthyosis and other hyperkeratotic conditions.
Swanbeck, G. (1968) · PubMed · Cited by 77
Proceedings of the Psoriasis Combination and Rotation Therapy Conference
Menter, M. A., See, J., AMEND, W. J. C., Ellis, C. N., Krueger, G. G., Lebwohl, M. G., Morison, W. L., & Prystowsky, J. H. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)80148-4 · Cited by 76
Asadullah, K., Schmid, H., Friedrich, M., Randow, F., Volk, H., Sterry, W., & Döcke, W. (1997) · Archives of Dermatological Research · doi:10.1007/s004030050251 · Cited by 73
Self-citationIsotretinoin vs Etretinate Therapy in Generalized Pustular and Chronic Psoriasis
Moy, R. L. (1985) · Archives of Dermatology · doi:10.1001/archderm.1985.01660100077019 · Cited by 69
The Role of Liver Biopsies in Psoriatic Patients Receiving Long-term Methotrexate Treatment
Newman, M. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670210056007 · Cited by 68
Brockow, T., Schiener, R., Franke, A., Resch, K., & Peter, R. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02152.x · Cited by 66
Schuller, E., Oppel, T., Bornhövd, E., Wetzel, S., & Wollenberg, A. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.021 · Cited by 64
Tar Gel-Phototherapy for Psoriasis
Frost, P. (1979) · Archives of Dermatology · doi:10.1001/archderm.1979.04010070016013 · Cited by 64
Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis
Grundmann-Kollmann, M., Ludwig, R. J., Zollner, T. M., Ochsendorf, F. R., Thaçi, D., Boehncke, W., Krutmann, J., Kaufmann, R., & Podda, M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)00792-8 · Cited by 60
Self-citationEffectiveness of cyclosporine treatment in severe psoriasis: A clinical and immunologic study
Finzi, A. F., Mozzanica, N., Cattaneo, A., Chiappino, G., & Pigatto, P. D. M. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70154-7 · Cited by 59
Cooper, Herd, Priestley, & Hunter, A. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00589.x · Cited by 58
Kalthoff, F., CHUNG, J., MUSSER, P., & Stuetz, A. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02225.x · Cited by 57
Gollnick, & MENTER (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.140s54018.x · Cited by 56
Parker, S., Coburn, P. R., AWRENCE, C. L., MARKS, J. M., & Shuster, S. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb07470.x · Cited by 55
Litjens, N. H. R., Nibbering, P. H., Barrois, A., Zomerdijk, T. P. L., Oudenrijn, A. C. V. D., Noz, K. C., Rademaker, M., van der Meide, P. H., van Dissel, J. T., & Thio, B. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05153.x · Cited by 55
Fleischer, A. B., Clark, A. R., Rapp, S. R., Reboussin, D. M., & Feldman, S. R. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12319272 · Cited by 53
Dead sea bath salt for the treatment of psoriasis vulgaris: a double-blind controlled study
Halevy, S., Giryes, H., Friger, M. D., & SUKENIK, S. (1997) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.1997.tb00509.x · Cited by 52
van de Kerkhof, P. C. M., van der Valk, P. G. M., Swinkels, O. Q. J., Kucharekova, M., de Rie, M. A., de Vries, H. J. C., Damstra, R. J., Oranje, A. P., der Spek, F. B. D. W., van Neer, P., et al. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07393.x · Cited by 51
Serwin, A. B., Wąsowicz, W., & Chodynicka, B. (2006) · Nutrition · doi:10.1016/j.nut.2006.05.011 · Cited by 51
Efficacy of Acitretin and Commercial Tanning Bed Therapy for Psoriasis
Carlin, C. S., Callis, K. P., & Krueger, G. G. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.4.436 · Cited by 51
Leenutaphong, V., Nimkulrat, P., & Sudtim, S. (2000) · Photodermatology Photoimmunology & Photomedicine · doi:10.1034/j.1600-0781.2000.160502.x · Cited by 50
Weston, W. L., Fennessey, P. V., Morelli, J. G., Schwab, H. P., Mooney, J. J., Samson, C. R., Huff, L., Harrison, L., & Gotlin, R. W. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12461062 · Cited by 49
Cassano, N., Loconsole, F., Galluccio, A. G., Miracapillo, A., Pezza, M., & Vena, G. A. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/205873920601900123 · Cited by 49
Sperr, W. R., Agis, H., Czerwenka, K. F., Virgolini, I. J., Bankl, H. C., Müller, M. R., Zsebo, K. M., Lechner, K., & Valent, P. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70163-x · Cited by 48
Gollnick, H. P. M., & Dümmler, U. (1997) · Clinics in Dermatology · doi:10.1016/s0738-081x(97)00013-8 · Cited by 44
Ranjan, N., Sharma, N. L., Shanker, V., Mahajan, V. K., & Tegta, G. R. (2007) · Journal of Dermatological Treatment · doi:10.1080/09546630701499291 · Cited by 43
Trott, J., Gerber, W., Hammes, S., & Ockenfels, H. M. (2008) · PubMed · doi:10.1684/ejd.2008.0311 · Cited by 42
Self-citationGreen, L., & Sadoff, W. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-001-0031-z · Cited by 41
Nast, A., Reytan, N., Rosumeck, S., ERDMANN, R., & Rzany, B. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.02841.x · Cited by 36
Self-citation8‐methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis
Amornpinyokeit, N., & Asawanonda, P. (2006) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2006.00249.x · Cited by 35
Brockow, T., Schiener, R., Franke, A., Resch, K. L., & Peter, R. U. (2007) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.7099 · Cited by 34
Combination Therapy for Psoriasis
Hanke, C. W. (1979) · Archives of Dermatology · doi:10.1001/archderm.1979.04010090024017 · Cited by 34
Excimer Laser versus Narrow-Band UVB (311 nm) in the Treatment of Psoriasis Vulgaris
Goldinger, S. M., Dummer, R., Schmid, P., Vavricka, M. P., Burg, G., & Läuchli, S. (2006) · Dermatology · doi:10.1159/000093852 · Cited by 33
Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman’s therapy
Andrýs, C., Borská, L., Pohl, D., Fiala, Z., Hamáková, K., & Krejsek, J. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-006-0723-8 · Cited by 32
Torras, H., Aliaga, A., López-Estebaranz, J. L., Hernández‐Aguado, I., Gardeazábal, J., Quintanilla, E., & Mascaró, J. M. (2004) · Journal of Dermatological Treatment · doi:10.1080/09546630410023322 · Cited by 32
A reappraisal of the use of 5‐methoxypsoralen in the therapy of psoriasis
Calzavara‐Pinton, P., Ortel, B. J., Carlino, A., Hönigsmann, H., & Panfilis, G. D. (1992) · Experimental Dermatology · doi:10.1111/j.1600-0625.1992.tb00071.x · Cited by 30
Nast, A., ERDMANN, R., Pathirana, D., & Rzany, B. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.00971.x · Cited by 30
Self-citationAsawanonda, P., Amornpinyokeit, N., & Nimnuan, C. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02328.x · Cited by 30
Empfehlungen zur Erfassung von Lebensqualität in der Dermatologie
Augustin, M., Amon, U., Bullinger, M., et al. (2000) · Dermatology and Psychosomatics / Dermatologie und Psychosomatik · doi:10.1159/000017504 · Cited by 29
Self-citationPsoralens and UV-A and UV-B Twice Weekly for the Treatment of Psoriasis
Diette, K. M. (1984) · Archives of Dermatology · doi:10.1001/archderm.1984.01650450051017 · Cited by 29
Vongthongsri, R., Konschitzky, R., Seeber, A., Treitl, C., Hönigsmann, H., & Tanew, A. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.024 · Cited by 28
Khurshid, K., Haroon, T. S., Hussain, I., et al. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00913.x · Cited by 28
Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
Caca-Biljanovska, N., & V'lckova-Laskoska, M. T. (2002) · PubMed · Cited by 28
Berg, M., & Ros, A. M. (1994) · PubMed · Cited by 28
de Leeuw, J., Lingen, R. G. V., Both, H., Tank, B., Nijsten, T. E. C., & Neumann, H. A. M. (2008) · Dermatologic Surgery · doi:10.1097/00042728-200901000-00012 · Cited by 27
Briffa, D. V., Rogers, S., Greaves, M. W., MARKS, J. M., Shuster, S., & WARIN, A. P. (1978) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1978.tb01512.x · Cited by 27
LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
Bagel, J. (2009) · PubMed · Cited by 26
van de Kerkhof, P. C. M., Green, C., Hamberg, K. J., Hutchinson, P. E., Jensen, J., Kidson, P., Kragballe, K., Larsen, F. G., Munro, C. S., & Tillman, D. M. (2002) · Dermatology · doi:10.1159/000057884 · Cited by 25
Housman, T. S., Keil, K. A., Mellen, B. G., McCarty, M. A., Fleischer, A. B., & Feldman, S. R. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.417 · Cited by 25
Different narrowband UVB dosage regimens in dark skinned psoriatics: a preliminary study
Youssef, R. M., Mahgoub, D. A., Mashaly, H. M., El-Nabarawy, E. A., Samir, N., & El-Mofty, M. A. (2008) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2008.00371.x · Cited by 25
Kirby, Buckley, & ROGERS (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02766.x · Cited by 24
Ockenfels, H. M., Nu�baum, G., Schultewolter, T., Burger, P. M., & Goos, M. (1995) · Archives of Dermatological Research · doi:10.1007/bf01105083 · Cited by 21
Self-citationBrazzelli, V., Barbagallo, T., Prestinari, F., Rona, C., Silvestri, A. D., Trevisan, V., & Borroni, G. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800419 · Cited by 19
Inhibition of human monocyte functions by anthralin
Mrowietz, U., FALSAFI, M., SCHRODER, J.-M., & Christophers, E. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00458.x · Cited by 18
Self-citationTwice‐ vs. thrice‐weekly MPD PUVA in psoriasis: a randomized‐controlled efficacy study
Valbuena, M. C., Hernández, O., Rey, M., Sánchez, G., & de Quintana, L. P. (2007) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2007.00294.x · Cited by 10
Cited by
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Self-citationThe Inflammatory Response in Psoriasis: a Comprehensive Review
Deng, Y., Chang, C., & Lu, Q. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8535-x · Cited by 416
Fujita, H., Terui, T., Hayama, K., Akiyama, M., Ikeda, S., Mabuchi, T., Ozawa, A., Kanekura, T., Kurosawa, M., Komine, M., et al. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14523 · Cited by 254
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Brück, J., Dringen, R., Amasuno, A., Pau‐Charles, I., & Ghoreschi, K. (2018) · Experimental Dermatology · doi:10.1111/exd.13548 · Cited by 128
Sozzani, S., Abbracchio, M. P., Annese, V., Danese, S., De Pità, O., De Sarro, G., Maione, S., Olivieri, I., Parodi, A., & Sarzi-Puttini, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.897333 · Cited by 22
Metadata
- Authors
- Nast, A., Boehncke, W., Mrowietz, U., Ockenfels, H., Philipp, S., Reich, K., Rosenbach, T., Sammain, A., Schlaeger, M., Sebastian, M., Sterry, W., Streit, V., Augustin, M., Erdmann, R., Klaus, J., Koza, J., Muller, S., Orzechowski, H., Rosumeck, S., Schmid‐Ott, G., Weberschock, T., & Rzany, B.
- Venue
- JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Publisher
- Wiley
- Published
- 2012-03
- Volume
- 10
- Issue
- s2
- Pages
- S1-95
- ISSN
- 1610-0379 (ISSN-L)
- 1610-0387
- OpenAlex
- W2063379728
- Cited by
- 272
- References
- 182
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.